Clearmind Medicine Inc.CMNDNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank56
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P56
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.23% |
| Q3 2025 | -7.42% |
| Q2 2025 | 18.11% |
| Q1 2025 | 0.13% |
| Q4 2024 | -8.11% |
| Q3 2024 | -14.66% |
| Q2 2024 | 4.25% |
| Q1 2024 | 20.94% |
| Q4 2023 | -61.54% |
| Q3 2023 | 35.44% |
| Q2 2023 | 7.91% |
| Q1 2023 | -52.49% |
| Q4 2022 | 12.57% |
| Q3 2022 | 40.15% |
| Q2 2022 | -46.83% |
| Q1 2022 | 7.79% |
| Q4 2021 | -106.03% |
| Q3 2021 | -496.34% |
| Q2 2021 | -88.44% |
| Q1 2021 | -29.78% |
| Q4 2020 | -7.84% |
| Q3 2020 | -11.68% |
| Q2 2020 | -150.67% |
| Q1 2020 | -0.77% |
| Q4 2019 | -15.27% |
| Q3 2019 | 41.47% |
| Q2 2019 | -67.81% |
| Q1 2019 | 89.16% |
| Q4 2018 | -952.45% |
| Q3 2018 | -282.70% |
| Q2 2018 | 82.54% |
| Q1 2018 | -452.82% |
| Q4 2017 | 0.00% |